MSF Continues Efforts to Reduce Pneumonia Vaccine Price so More Kids Can Be Protected

MSF Continues Efforts to Reduce Pneumonia Vaccine Price so More Kids Can Be ProtectedDoctors Without Borders/M édecins Sans Frontières (MSF) is challenging a recent Indian court decision to give U.S. pharmaceutical corporation Pfizer a patent it doesn't deserve on its pneumonia vaccine Prevnar13 (PCV13). This decision solidifies Pfizer's monopoly across the globe and prevents vaccine manufacturers in India from making and selling more affordable versions of PCV13 for people in India and other countries where the patent exists until 2026.
Source: MSF News - Category: International Medicine & Public Health Authors: Source Type: news